H
Hongxing Zhang
Researcher at Peking Union Medical College
Publications - 47
Citations - 813
Hongxing Zhang is an academic researcher from Peking Union Medical College. The author has contributed to research in topics: Survival rate & Radiation therapy. The author has an hindex of 14, co-authored 46 publications receiving 650 citations.
Papers
More filters
Journal ArticleDOI
Etoposide and cisplatin versus paclitaxel and carboplatin with concurrent thoracic radiotherapy in unresectable stage III non-small cell lung cancer: a multicenter randomized phase III trial
Jun Liang,Nan Bi,S. Wu,Ming Chen,C. Lv,L. Zhao,A. Shi,Wei Jiang,Yaomin Xu,Zongmei Zhou,Wei Wang,Dongfu Chen,Zhouguang Hui,J. Lv,Hongxing Zhang,Qinfu Feng,Zefen Xiao,Xin Wang,Lipin Liu,Tao Zhang,Liping Du,Wei Chen,Yu Shyr,Weibo Yin,Jian Li,Jie He,Luhua Wang +26 more
TL;DR: EP might be superior to weekly PC in terms of OS in the setting of concurrent chemoradiation for unresectable stage III NSCLC.
Journal ArticleDOI
Curative radiotherapy of early operable non-small cell lung cancer.
Hongxing Zhang,Wei Bo Yin,Li-Jun Zhang,Zong Yi Yang,Zhi Man Zhang,Mei Wang,Dong Fu Chen,Xian Zhi Gu +7 more
TL;DR: It is shown that early non-small cell lung cancer can be cured by radiotherapy alone giving survival rates comparable to surgery and Prospective randomized clinical trials are warranted.
Journal ArticleDOI
Postoperative Radiotherapy for Resected Pathological Stage IIIA–N2 Non-Small Cell Lung Cancer: A Retrospective Study of 221 Cases from a Single Institution
Honghai Dai,Zhouguang Hui,W. Ji,Jun Liang,Ji-ma Lü,Guangfei Ou,Zongmei Zhou,Qinfu Feng,Zefen Xiao,Dongfu Chen,Hongxing Zhang,Weibo Yin,Jie He,Luhua Wang +13 more
TL;DR: PORT can significantly improve the survival of patients with resected pathological stage IIIA-N2 NSCLC and a prospective randomized multicenter clinical trial is ongoing.
Journal ArticleDOI
Role of adjuvant radiotherapy for stage ii thymoma after complete tumor resection
Yi-Dong Chen,Qinfu Feng,Hai-Zhen Lu,Yousheng Mao,Zongmei Zhou,Guangfei Ou,Mei Wang,Jun Zhao,Hongxing Zhang,Zefen Xiao,Dongfu Chen,Jun Liang,Yirui Zhai,Luhua Wang,Jie He +14 more
TL;DR: Adjuvant radiotherapy after complete tumor resection for patients with stage II thymoma did not significantly reduce recurrence rates or improve survival rates, and patients with type B3 thymomas had the lowest disease-free survival rates among all subtypes.
Journal ArticleDOI
The Impact of Postoperative Conformal Radiotherapy after Radical Surgery on Survival and Recurrence in Pathologic T3N0M0 Esophageal Carcinoma: A Propensity Score-Matched Analysis
Jinsong Yang,Wencheng Zhang,Zefen Xiao,Qifeng Wang,Zongmei Zhou,Hongxing Zhang,Dongfu Chen,Q. Feng,Jie He,Shugeng Gao,Kelin Sun,Xiangyang Liu,Dekang Fang,Juwei Mu,Dali Wang,Yexiong Li +15 more
TL;DR: Postoperative radiotherapy using cRT is strongly associated with improved OS and DFS in patients with pT3N0M0 TESCC and a multicenter, randomized phase III clinical trial is warranted to confirm these findings.